Acute management of sick infants with suspected inborn errors of metabolism

Neerja Gupta1, Madhulika Kabra

  • 1Division of Genetics, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. neerjaagarwal@yahoo.co.in

Insights

Diagnosing inborn errors of metabolism in critically ill infants requires prompt suspicion and treatment, even before a definitive diagnosis. Initial tests and preserved samples are crucial for classifying these rare pediatric conditions.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Genetics

Background:

  • Inborn errors of metabolism (IEM) present diagnostic challenges in critically ill infants.
  • These conditions often mimic common pediatric illnesses, delaying diagnosis and treatment.
  • Early recognition is vital for managing severe metabolic disruptions.

Purpose of the Study:

  • To highlight the importance of early suspicion and prompt management of IEM in critically ill infants.
  • To emphasize the role of initial screening investigations in categorizing IEM.
  • To stress the necessity of sample preservation for definitive diagnosis.

Main Methods:

  • Review of diagnostic approaches for IEM in critically ill infants.
  • Analysis of initial screening investigations for classifying metabolic disorders.
  • Emphasis on clinical suspicion and immediate treatment initiation.

Main Results:

  • High index of suspicion is critical for diagnosing IEM in sick infants.
  • Initial investigations provide clues for broad categorization of IEM.
  • Prompt treatment initiation is essential, irrespective of immediate diagnostic certainty.

Conclusions:

  • Timely diagnosis and management of IEM in infants are crucial for improving outcomes.
  • Screening tests and sample preservation aid in classifying and confirming IEM.
  • Pediatric critical care must integrate awareness of IEM for effective patient care.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...